MedPath

Deacon Biosciences, Inc.

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol® Following Topical Periocular Administration in Healthy Volunteers

Phase 2
Completed
Conditions
Ocular Infection
Interventions
Drug: Unisol
First Posted Date
2013-05-15
Last Posted Date
2016-02-11
Lead Sponsor
Deacon Biosciences, Inc.
Target Recruit Count
62
Registration Number
NCT01853722
Locations
🇺🇸

Andover Eye Associates, Andover, Massachusetts, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.